loadpatents
name:-0.11817002296448
name:-0.096735000610352
name:-0.1518349647522
KOWALEWSKI; Daniel Johannes Patent Filings

KOWALEWSKI; Daniel Johannes

Patent Applications and Registrations

Patent applications and USPTO patent grants for KOWALEWSKI; Daniel Johannes.The latest application filed is for "immunotherapy with b*07 restricted peptides and combination of peptides against cancers and related methods".

Company Profile
184.111.142
  • KOWALEWSKI; Daniel Johannes - Tuebingen DE
  • Kowalewski; Daniel Johannes - Kirchentellinsfurt DE
  • Kowalewski; Daniel Johannes - Tubingen DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220306721 - SCHUSTER; Heiko ;   et al.
2022-09-29
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220289816 - SCHUSTER; Heiko ;   et al.
2022-09-15
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220289817 - SCHUSTER; Heiko ;   et al.
2022-09-15
Method For The Absolute Quantification Of Mhc Molecules
App 20220283176 - SCHRAEDER; Christoph ;   et al.
2022-09-08
Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
Grant 11,433,099 - Schimmack , et al. September 6, 2
2022-09-06
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220267408 - SCHUSTER; Heiko ;   et al.
2022-08-25
Peptides Displayed By Hla For Use In Immunotherapy Against Different Types Of Cancers
App 20220226376 - HANNEN; Ricarda ;   et al.
2022-07-21
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,376,281 - Schuster , et al. July 5, 2
2022-07-05
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,369,636 - Schuster , et al. June 28, 2
2022-06-28
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,357,797 - Schuster , et al. June 14, 2
2022-06-14
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers
App 20220118016 - WALZ; Juliane Sarah ;   et al.
2022-04-21
Amidated Peptides And Their Deamidated Counterparts Displayed By Hla-a*02 For Use In Immunotherapy Against Different Types Of Cancers
App 20220111022 - HUKELMANN; Jens ;   et al.
2022-04-14
Amidated Peptides And Their Deamidated Counterparts Displayed By Non-hla-a*02 For Use In Immunotherapy Against Different Types Of Cancers
App 20220098269 - HUKELMANN; Jens ;   et al.
2022-03-31
A*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,246,917 - Song , et al. February 15, 2
2022-02-15
Immunotherapy With B*08 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220008471 - SCHIMMACK; Gisela ;   et al.
2022-01-13
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220009982 - SCHUSTER; Heiko ;   et al.
2022-01-13
Immunotherapy With B*08 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220008472 - SCHIMMACK; Gisela ;   et al.
2022-01-13
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220002366 - SCHUSTER; Heiko ;   et al.
2022-01-06
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20220000922 - SCHUSTER; Heiko ;   et al.
2022-01-06
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20220002374 - SCHUSTER; Heiko ;   et al.
2022-01-06
Peptides for use in immunotherapy against cancers
Grant 11,214,604 - Song , et al. January 4, 2
2022-01-04
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210401892 - SCHUSTER; Heiko ;   et al.
2021-12-30
Peptides for use in immunotherapy against cancers
Grant 11,208,449 - Song , et al. December 28, 2
2021-12-28
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,208,448 - Song , et al. December 28, 2
2021-12-28
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,197,892 - Schuster , et al. December 14, 2
2021-12-14
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,179,418 - Schuster , et al. November 23, 2
2021-11-23
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210338734 - SCHUSTER; Heiko ;   et al.
2021-11-04
Peptides For Use In Immunotherapy Against Cancers
App 20210340202 - SONG; Colette ;   et al.
2021-11-04
Peptides For Use In Immunotherapy Against Cancers
App 20210340203 - SONG; Colette ;   et al.
2021-11-04
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210338735 - SCHUSTER; Heiko ;   et al.
2021-11-04
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210330771 - SONG; Colette ;   et al.
2021-10-28
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210330772 - SONG; Colette ;   et al.
2021-10-28
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210330708 - SCHUSTER; Heiko ;   et al.
2021-10-28
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,154,576 - Schuster , et al. October 26, 2
2021-10-26
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,155,590 - Song , et al. October 26, 2
2021-10-26
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers
App 20210322478 - WALZ; Juliane Sarah ;   et al.
2021-10-21
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,147,839 - Schuster , et al. October 19, 2
2021-10-19
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,147,838 - Schuster , et al. October 19, 2
2021-10-19
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 11,142,556 - Schuster , et al. October 12, 2
2021-10-12
Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers
Grant 11,141,437 - Schuster , et al. October 12, 2
2021-10-12
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers
Grant 11,135,246 - Walz , et al. October 5, 2
2021-10-05
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,117,941 - Song , et al. September 14, 2
2021-09-14
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210277080 - SONG; Colette ;   et al.
2021-09-09
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,111,281 - Song , et al. September 7, 2
2021-09-07
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,103,535 - Schuster , et al. August 31, 2
2021-08-31
Peptides and combination thereof for use in the immunotherapy against cancers
Grant 11,103,534 - Walz , et al. August 31, 2
2021-08-31
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210260120 - SCHUSTER; Heiko ;   et al.
2021-08-26
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210244765 - SCHUSTER; Heiko ;   et al.
2021-08-12
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20210238243 - SCHUSTER; Heiko ;   et al.
2021-08-05
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,077,142 - Schuster , et al. August 3, 2
2021-08-03
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210230240 - SONG; Colette ;   et al.
2021-07-29
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,065,279 - Schuster , et al. July 20, 2
2021-07-20
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers
App 20210213065 - WALZ; Juliane Sarah ;   et al.
2021-07-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210213064 - SCHUSTER; Heiko ;   et al.
2021-07-15
A*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,058,755 - Song , et al. July 13, 2
2021-07-13
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,058,727 - Schuster , et al. July 13, 2
2021-07-13
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,052,114 - Schuster , et al. July 6, 2
2021-07-06
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,052,113 - Schuster , et al. July 6, 2
2021-07-06
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,040,069 - Schuster , et al. June 22, 2
2021-06-22
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,033,583 - Schuster , et al. June 15, 2
2021-06-15
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,033,585 - Schuster , et al. June 15, 2
2021-06-15
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,026,977 - Schuster , et al. June 8, 2
2021-06-08
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers
App 20210161962 - WALZ; Juliane Sarah ;   et al.
2021-06-03
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,020,433 - Schuster , et al. June 1, 2
2021-06-01
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,020,434 - Schuster , et al. June 1, 2
2021-06-01
Peptides and combination thereof for use in the immunotherapy against cancers
Grant 11,020,432 - Walz , et al. June 1, 2
2021-06-01
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,013,768 - Schuster , et al. May 25, 2
2021-05-25
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,013,766 - Schuster , et al. May 25, 2
2021-05-25
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 11,013,769 - Schuster , et al. May 25, 2
2021-05-25
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 11,014,972 - Song , et al. May 25, 2
2021-05-25
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210145886 - SCHUSTER; Heiko ;   et al.
2021-05-20
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210145887 - SCHUSTER; Heiko ;   et al.
2021-05-20
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210145888 - SCHUSTER; Heiko ;   et al.
2021-05-20
Peptides and combination thereof for use in the immunotherapy against cancers
Grant 11,007,223 - Walz , et al. May 18, 2
2021-05-18
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210137986 - SCHUSTER; Heiko ;   et al.
2021-05-13
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210138052 - SONG; Colette ;   et al.
2021-05-13
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210137985 - SCHUSTER; Heiko ;   et al.
2021-05-13
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 11,001,617 - Schuster , et al. May 11, 2
2021-05-11
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210128707 - SONG; Colette ;   et al.
2021-05-06
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210128708 - SONG; Colette ;   et al.
2021-05-06
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,993,962 - Schuster , et al. May 4, 2
2021-05-04
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,993,964 - Schuster , et al. May 4, 2
2021-05-04
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers
Grant 10,993,963 - Walz , et al. May 4, 2
2021-05-04
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210113619 - SCHUSTER; Heiko ;   et al.
2021-04-22
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers
App 20210107941 - RAMMENSEE; Hans-Georg ;   et al.
2021-04-15
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20210094992 - SONG; Colette ;   et al.
2021-04-01
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 10,954,281 - Schuster , et al. March 23, 2
2021-03-23
*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,946,081 - Song , et al. March 16, 2
2021-03-16
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210069251 - SCHUSTER; Heiko ;   et al.
2021-03-11
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210060074 - SCHUSTER; Heiko ;   et al.
2021-03-04
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210060078 - SCHUSTER; Heiko ;   et al.
2021-03-04
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210060077 - SCHUSTER; Heiko ;   et al.
2021-03-04
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210052652 - SCHUSTER; Heiko ;   et al.
2021-02-25
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210052653 - SCHUSTER; Heiko ;   et al.
2021-02-25
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210052654 - SCHUSTER; Heiko ;   et al.
2021-02-25
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20210052651 - SCHUSTER; Heiko ;   et al.
2021-02-25
A*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,925,947 - Song , et al. February 23, 2
2021-02-23
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
Grant 10,925,949 - Rammensee , et al. February 23, 2
2021-02-23
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
Grant 10,919,933 - Rammensee , et al. February 16, 2
2021-02-16
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,905,719 - Schuster , et al. February 2, 2
2021-02-02
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,905,720 - Schuster , et al. February 2, 2
2021-02-02
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
Grant 10,906,938 - Rammensee , et al. February 2, 2
2021-02-02
Novel Immunotherapy Against Several Tumors Of The Blood, Such As Acute Myeloid Leukemia (aml)
App 20210023189 - RAMMENSEE; Hans-Georg ;   et al.
2021-01-28
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
Grant 10,899,794 - Rammensee , et al. January 26, 2
2021-01-26
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
Grant 10,898,562 - Rammensee , et al. January 26, 2
2021-01-26
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,898,519 - Schuster , et al. January 26, 2
2021-01-26
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,899,810 - Song , et al. January 26, 2
2021-01-26
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,898,518 - Schuster , et al. January 26, 2
2021-01-26
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 10,899,814 - Schuster , et al. January 26, 2
2021-01-26
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 10,899,813 - Schuster , et al. January 26, 2
2021-01-26
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 10,899,812 - Schuster , et al. January 26, 2
2021-01-26
B*44 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,899,811 - Song , et al. January 26, 2
2021-01-26
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,894,064 - Schuster , et al. January 19, 2
2021-01-19
Novel Immunotherapy Against Several Tumors Of The Blood, Such As Acute Myeloid Leukemia (aml)
App 20210008189 - RAMMENSEE; Hans-Georg ;   et al.
2021-01-14
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,888,583 - Schuster , et al. January 12, 2
2021-01-12
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,888,582 - Schuster , et al. January 12, 2
2021-01-12
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,888,584 - Schuster , et al. January 12, 2
2021-01-12
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,888,586 - Schuster , et al. January 12, 2
2021-01-12
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,888,585 - Schuster , et al. January 12, 2
2021-01-12
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
Grant 10,889,617 - Rammensee , et al. January 12, 2
2021-01-12
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,874,695 - Schuster , et al. December 29, 2
2020-12-29
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
Grant 10,875,892 - Walz , et al. December 29, 2
2020-12-29
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,874,696 - Schuster , et al. December 29, 2
2020-12-29
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200399334 - SONG; Colette ;   et al.
2020-12-24
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,890 - Schuster , et al. December 22, 2
2020-12-22
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,895 - Schuster , et al. December 22, 2
2020-12-22
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,896 - Schuster , et al. December 22, 2
2020-12-22
A*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,869,917 - Song , et al. December 22, 2
2020-12-22
Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods
Grant 10,870,685 - Schuster , et al. December 22, 2
2020-12-22
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,894 - Schuster , et al. December 22, 2
2020-12-22
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,893 - Schuster , et al. December 22, 2
2020-12-22
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,892 - Schuster , et al. December 22, 2
2020-12-22
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,869,891 - Schuster , et al. December 22, 2
2020-12-22
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200392194 - SONG; Colette ;   et al.
2020-12-17
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200360433 - SCHUSTER; Heiko ;   et al.
2020-11-19
A*03 restricted peptides for use in immunotherapy against cancers and related methods
Grant 10,828,357 - Song , et al. November 10, 2
2020-11-10
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers
App 20200339657 - WALZ; Juliane Sarah ;   et al.
2020-10-29
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers
App 20200339656 - WALZ; Juliane Sarah ;   et al.
2020-10-29
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers
App 20200339658 - WALZ; Juliane Sarah ;   et al.
2020-10-29
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200339646 - SONG; Colette ;   et al.
2020-10-29
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200339645 - SONG; Colette ;   et al.
2020-10-29
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200339644 - SONG; Colette ;   et al.
2020-10-29
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)
Grant 10,813,985 - Rammensee , et al. October 27, 2
2020-10-27
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,813,953 - Schuster , et al. October 27, 2
2020-10-27
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200325197 - SCHUSTER; Heiko ;   et al.
2020-10-15
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll)
App 20200325174 - WALZ; Juliane ;   et al.
2020-10-15
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200323970 - SONG; Colette ;   et al.
2020-10-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323919 - SCHUSTER; Heiko ;   et al.
2020-10-15
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200325195 - SCHUSTER; Heiko ;   et al.
2020-10-15
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200325196 - SCHUSTER; Heiko ;   et al.
2020-10-15
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200325199 - SCHUSTER; Heiko ;   et al.
2020-10-15
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200325198 - SCHUSTER; Heiko ;   et al.
2020-10-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323918 - SCHUSTER; Heiko ;   et al.
2020-10-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323916 - SCHUSTER; Heiko ;   et al.
2020-10-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323909 - SCHUSTER; Heiko ;   et al.
2020-10-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323907 - SCHUSTER; Heiko ;   et al.
2020-10-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323910 - SCHUSTER; Heiko ;   et al.
2020-10-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323911 - SCHUSTER; Heiko ;   et al.
2020-10-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323915 - SCHUSTER; Heiko ;   et al.
2020-10-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323913 - SCHUSTER; Heiko ;   et al.
2020-10-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200323906 - SCHUSTER; Heiko ;   et al.
2020-10-15
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
Grant 10,799,571 - Rammensee , et al. October 13, 2
2020-10-13
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,799,537 - Schuster , et al. October 13, 2
2020-10-13
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,792,307 - Schuster , et al. October 6, 2
2020-10-06
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,792,308 - Schuster , et al. October 6, 2
2020-10-06
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200306308 - SCHUSTER; Heiko ;   et al.
2020-10-01
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200306305 - SCHUSTER; Heiko ;   et al.
2020-10-01
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers
App 20200308225 - RAMMENSEE; Hans-Georg ;   et al.
2020-10-01
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200306311 - SCHUSTER; Heiko ;   et al.
2020-10-01
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers
App 20200308227 - RAMMENSEE; Hans-Georg ;   et al.
2020-10-01
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers
App 20200308226 - RAMMENSEE; Hans-Georg ;   et al.
2020-10-01
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200297770 - SCHUSTER; Heiko ;   et al.
2020-09-24
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200297771 - SCHUSTER; Heiko ;   et al.
2020-09-24
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200297772 - SCHUSTER; Heiko ;   et al.
2020-09-24
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,780,124 - Schuster , et al. Sept
2020-09-22
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
Grant 10,781,233 - Rammensee , et al. Sept
2020-09-22
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,780,123 - Schuster , et al. Sept
2020-09-22
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,780,122 - Schuster , et al. Sept
2020-09-22
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200289632 - SONG; Colette ;   et al.
2020-09-17
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,772,915 - Schuster , et al. September 15, 2
2020-09-15
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200268799 - SCHUSTER; Heiko ;   et al.
2020-08-27
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200268800 - SCHUSTER; Heiko ;   et al.
2020-08-27
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200268798 - SCHUSTER; Heiko ;   et al.
2020-08-27
Novel Immunotherapy Against Several Tumors Of The Blood, Such As Acute Myeloid Leukemia (aml)
App 20200268862 - RAMMENSEE; Hans-Georg ;   et al.
2020-08-27
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,751,369 - Schuster , et al. A
2020-08-25
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200261504 - SCHUSTER; Heiko ;   et al.
2020-08-20
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200261505 - SCHUSTER; Heiko ;   et al.
2020-08-20
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200261506 - SCHUSTER; Heiko ;   et al.
2020-08-20
Novel Immunotherapy Against Several Tumors Of The Blood, Such As Acute Myeloid Leukemia (aml)
App 20200254078 - Kind Code
2020-08-13
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
Grant 10,730,910 - Walz , et al.
2020-08-04
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers
App 20200223900 - WALZ; Juliane Sarah ;   et al.
2020-07-16
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200222465 - SCHUSTER; Heiko ;   et al.
2020-07-16
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,709,738 - Schuster , et al.
2020-07-14
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,709,736 - Schuster , et al.
2020-07-14
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,709,737 - Schuster , et al.
2020-07-14
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,702,553 - Schuster , et al.
2020-07-07
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers
App 20200207831 - WALZ; Juliane Sarah ;   et al.
2020-07-02
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200206268 - SCHUSTER; Heiko ;   et al.
2020-07-02
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,695,374 - Schuster , et al.
2020-06-30
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,695,373 - Schuster , et al.
2020-06-30
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,695,375 - Schuster , et al.
2020-06-30
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,695,376 - Schuster , et al.
2020-06-30
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
Grant 10,695,377 - Schuster , et al.
2020-06-30
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers
App 20200199193 - WALZ; Juliane Sarah ;   et al.
2020-06-25
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200197441 - SCHUSTER; Heiko ;   et al.
2020-06-25
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers
App 20200199194 - WALZ; Juliane Sarah ;   et al.
2020-06-25
Immunotherapy With B*08 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200188438 - SCHIMMACK; Gisela ;   et al.
2020-06-18
Peptides And Combination Thereof For Use In The Immunotherapy Against Cancers
App 20200190160 - WALZ; Juliane Sarah ;   et al.
2020-06-18
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200179454 - SCHUSTER; Heiko ;   et al.
2020-06-11
Peptides And Combination Of Peptides For Use In Immunotherapy Against Leukemias And Other Cancers
App 20200181233 - WALZ; Juliane Sarah ;   et al.
2020-06-11
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200179453 - SCHUSTER; Heiko ;   et al.
2020-06-11
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200171091 - SCHUSTER; Heiko ;   et al.
2020-06-04
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
Grant 10,668,137 - Rammensee , et al.
2020-06-02
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200163996 - SCHUSTER; Heiko ;   et al.
2020-05-28
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200155604 - SCHUSTER; Heiko ;   et al.
2020-05-21
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200155605 - SCHUSTER; Heiko ;   et al.
2020-05-21
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll)
App 20200157148 - WALZ; Juliane ;   et al.
2020-05-21
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200108097 - SCHUSTER; Heiko ;   et al.
2020-04-09
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200093862 - SCHUSTER; Heiko ;   et al.
2020-03-26
Novel Immunotherapy Against Several Tumors Of The Blood, Such As Acute Myeloid Leukemia (aml)
App 20200093905 - RAMMENSEE; Hans-Georg ;   et al.
2020-03-26
Immunotherapy With A*01 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200087364 - SCHUSTER; Heiko ;   et al.
2020-03-19
B*44 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200087363 - SONG; Colette ;   et al.
2020-03-19
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200085874 - SCHUSTER; Heiko ;   et al.
2020-03-19
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200085873 - SCHUSTER; Heiko ;   et al.
2020-03-19
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
Grant 10,570,175 - Walz , et al. Feb
2020-02-25
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
App 20200038446 - SCHUSTER; Heiko ;   et al.
2020-02-06
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200038448 - SCHUSTER; Heiko ;   et al.
2020-02-06
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20200038447 - SCHUSTER; Heiko ;   et al.
2020-02-06
Immunotherapy With B*07 Restricted Peptides And Combination Of Peptides Against Cancers And Related Methods
App 20200040057 - SCHUSTER; Heiko ;   et al.
2020-02-06
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
Grant 10,525,115 - Rammensee , et al. J
2020-01-07
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200000895 - SONG; Colette ;   et al.
2020-01-02
A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
App 20200000897 - SONG; Colette ;   et al.
2020-01-02
Peptides For Use In Immunotherapy Against Cancers
App 20190352359 - SONG; Colette ;   et al.
2019-11-21
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
Grant 10,450,346 - Walz , et al. Oc
2019-10-22
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll)
App 20190284234 - WALZ; Juliane ;   et al.
2019-09-19
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll)
App 20190284233 - WALZ; Juliane ;   et al.
2019-09-19
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers
App 20190284235 - RAMMENSEE; Hans-Georg ;   et al.
2019-09-19
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers
App 20190284236 - Rammensee; Hans-Georg ;   et al.
2019-09-19
Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
App 20190275130 - RAMMENSEE; Hans-Georg ;   et al.
2019-09-12
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20190255112 - SCHUSTER; Heiko ;   et al.
2019-08-22
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20190255113 - SCHUSTER; Heiko ;   et al.
2019-08-22
Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers
App 20190255110 - SCHUSTER; Heiko ;   et al.
2019-08-22
Peptides And Combination Of Peptides Of Non-canonical Origin For Use In Immunotherapy Against Different Types Of Cancers
App 20190255164 - Schuster; Heiko ;   et al.
2019-08-22
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
Grant 10,377,797 - Rammensee , et al. A
2019-08-13
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
Grant 10,364,271 - Walz , et al.
2019-07-30
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
Grant 10,286,052 - Rammensee , et al.
2019-05-14
Novel Cell Epitopes And Combination Of Cell Epitopes For Use In The Immunotherapy Of Myeloma And Other Cancers
App 20190077832 - Rammensee; Hans-Georg ;   et al.
2019-03-14
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll)
App 20190055286 - Walz; Juliane ;   et al.
2019-02-21
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll)
App 20190002497 - STICKEL; Juliane ;   et al.
2019-01-03
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
Grant 10,167,317 - Stickel , et al. J
2019-01-01
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
Grant 10,144,763 - Stickel , et al. De
2018-12-04
Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
App 20180311330 - Rammensee; Hans-Georg ;   et al.
2018-11-01
Novel Immunotherapy Against Several Tumors Of The Blood, In Particular Chronic Lymphoid Leukemia (cll)
App 20180244722 - STICKEL; Juliane ;   et al.
2018-08-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed